Your browser doesn't support javascript.
loading
Real-World Effectiveness of Primary Series and Booster Doses of Inactivated Coronavirus Disease 2019 Vaccine Against Omicron BA.2 Variant Infection in China: A Retrospective Cohort Study.
Tang, Lin; Wang, Fu-Zhen; Rodewald, Lance E; Wang, Xuan-Yi; Liu, Si-Yu; Liu, Qian-Qian; Wang, Xiao-Qi; Wu, Dan; Li, Ming-Shuang; Zhang, Qian; Shao, Yi-Ming; Huang, Li-Fang; Song, Yu-Dan; Huang, Yong; Zeng, Xiang; Liu, Li-Jun; Yang, Hong; Huang, Ao-Di; Bao, Li-Ming; Zheng, Hui; Ma, Chao; Lv, Xiao-Ya; Song, Lei; Ma, Zhao; Wang, Shu-Guang; Ma, Hao; Guan, Wei-Jie; Wu, Zhi-Yin; Zhong, Nan-Shan; Yin, Zun-Dong.
Affiliation
  • Tang L; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing.
  • Wang FZ; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing.
  • Rodewald LE; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing.
  • Wang XY; Shanghai Institute of Infectious Disease and Biosecurity, Key Laboratory of Medical Molecular Virology of Ministry of Education and Ministry of Health, and Institutes of Biomedical Sciences, Medical College, Fudan University, Shanghai.
  • Liu SY; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing.
  • Liu QQ; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing.
  • Wang XQ; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing.
  • Wu D; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing.
  • Li MS; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing.
  • Zhang Q; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing.
  • Shao YM; State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing.
  • Huang LF; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing.
  • Song YD; Department of Immunization Program, Fujian Provincial Center for Disease Control and Prevention, Fuzhou.
  • Huang Y; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing.
  • Zeng X; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing.
  • Liu LJ; Department of Immunization Program, Guangzhou Center for Disease Control and Prevention, Guangzhou.
  • Yang H; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing.
  • Huang AD; China Field Epidemiology Training Program, Chinese Center for Disease Control and Prevention, Beijing.
  • Bao LM; Department of Immunization Program, Zhuhai Center for Disease Control and Prevention, Guangzhou.
  • Zheng H; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing.
  • Ma C; Department of Immunization Program, Sichuan Provincial Center for Disease Control and Prevention, Chengdu.
  • Lv XY; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing.
  • Song L; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing.
  • Ma Z; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing.
  • Wang SG; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing.
  • Ma H; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing.
  • Guan WJ; Development Center for Medicine and Science and Technology, National Health Commission, Beijing.
  • Wu ZY; Development Center for Medicine and Science and Technology, National Health Commission, Beijing.
  • Zhong NS; Development Center for Medicine and Science and Technology, National Health Commission, Beijing.
  • Yin ZD; Development Center for Medicine and Science and Technology, National Health Commission, Beijing.
J Infect Dis ; 228(3): 261-269, 2023 08 11.
Article in En | MEDLINE | ID: mdl-37005365
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adult / Child, preschool / Humans Country/Region as subject: Asia Language: En Journal: J Infect Dis Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adult / Child, preschool / Humans Country/Region as subject: Asia Language: En Journal: J Infect Dis Year: 2023 Type: Article